Asia Pacific Non-steroidal Anti-inflammatory Drugs Market Size & Outlook

The non-steroidal anti-inflammatory drugs market in Asia Pacific is expected to reach a projected revenue of US$ 7,519.8 million by 2030. A compound annual growth rate of 6.8% is expected of Asia Pacific non-steroidal anti-inflammatory drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$5,078.7
Forecast, 2030 (US$M)
$7,519.8
CAGR, 2025 - 2030
6.8%
Report Coverage
Asia Pacific

Asia Pacific non-steroidal anti-inflammatory drugs market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific non-steroidal anti-inflammatory drugs market highlights

  • The Asia Pacific non-steroidal anti-inflammatory drugs market generated a revenue of USD 5,078.7 million in 2024.
  • The market is expected to grow at a CAGR of 6.8% from 2025 to 2030.
  • In terms of segment, arthritis was the largest revenue generating disease indication in 2024.
  • Migraine is the most lucrative disease indication segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2025 to 2030.

Asia Pacific data book summary

Market revenue in 2024USD 5,078.7 million
Market revenue in 2030USD 7,519.8 million
Growth rate6.8% (CAGR from 2025 to 2030)
Largest segmentArthritis
Fastest growing segmentMigraine
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationArthritis, Migraine, Ophthalmic Diseases
Key market players worldwidePfizer Inc, Bayer AG, GSK PLC ADR, Dr Reddy's Laboratories Ltd ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd ADR, Johnson & Johnson, Merck & Co Inc

Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.5% of the global non-steroidal anti-inflammatory drugs market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 7,519.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non-steroidal Anti-inflammatory Drugs Market Companies

Name Profile # Employees HQ Website

Asia Pacific non-steroidal anti-inflammatory drugs market size, by country, 2018-2030 (US$M)

Asia Pacific Non-steroidal Anti-inflammatory Drugs Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific non-steroidal anti-inflammatory drugs market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more